Drug class
Antisense Oligonucleotide; Survival Motor Neuron-2-directed RNA Interaction
Mechanism of action
SPINRAZA is an antisense oligonucleotide (ASO) designed to treat SMA caused by mutations in chromosome 5q that lead to SMN protein deficiency.
General use cases
- Muscular Atrophy, Spinal
- spinal muscular atrophy (SMA) in pediatric and adult patients
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
